Dihexa
- Status
- Preclinical, , not approved for human use
- Evidence
Animal and cell only, graded on the Neuroplasticity Peptides bench
Dihexa is a synthetic peptide analogue of the angiotensin IV metabolite LVV-hemorphin-7, developed at Washington State University.
Reviewed
01Overview
What Dihexa is
It is considered one of the most potent cognitive enhancers ever tested in animal models — reportedly 7 orders of magnitude more potent than BDNF at improving cognitive performance in rodent Alzheimer's models. Exclusively used by the research and biohacking community with no human clinical trial data available.
How it works
Dihexa is a small-molecule analog derived from angiotensin IV (AngIV). It retains the Tyr-Ile core of Nle1-AngIV, with an N-terminal hexanoic acid cap and a C-terminal 6-aminohexanoic amide that give it metabolic stability and blood-brain-barrier penetration. In rodent studies it drives synaptogenesis, the formation of new dendritic spines and functional synapses, in the hippocampus. Its proposed mechanism is potentiation of the hepatocyte growth factor (HGF) / c-Met system: dihexa was reported to bind HGF (the ligand, not the c-Met receptor itself) and to augment HGF-dependent c-Met phosphorylation, activating downstream PI3K/Akt and MAPK/ERK signaling. Important caveat: the paper that established the HGF/c-Met binding mechanism (Benoist et al., J Pharmacol Exp Ther 2014) was retracted in April 2025 [PMID:40312093], and two earlier papers from the same laboratory were retracted in the same month, one on HGF dimerization-domain mimics [PMID:40312094] and one on a closely related family of angiotensin IV analogues developed as HGF/Met blockers [PMID:40312092]. The 2013 paper that introduced dihexa is not retracted but has carried an expression of concern since 2021 [PMID:34551989]. Treat the molecular target as unconfirmed. Independent work in an APP/PS1 Alzheimer's mouse model attributes dihexa's procognitive and anti-inflammatory effects to PI3K/Akt activation. This pathway is distinct from the BDNF/TrkB signaling used by many other neurotrophic nootropics.
Studied for
- Alzheimer's disease
- Cognitive impairment
- Synaptogenesis
- Neurodegeneration
Benefits listed
- Synaptogenesis: formation of new dendritic spines and functional synapses (preclinical)
- Memory and spatial-learning support in rodent models
- Potential research application in Alzheimer's and other neurodegenerative disease models
- HGF/c-Met and PI3K/Akt-linked neuroplasticity (mechanism proposed; key paper retracted)
What to expect
- No human efficacy data exists, so any effect in people is anecdotal and unverified
- Anecdotal users describe subtle improvements in mental clarity or verbal fluency over days to weeks; these reports are unblinded and unreliable
- Effects, if any, are attributed to synaptic remodeling rather than acute stimulation
- Because safety is unstudied, treat any use as a personal experiment with unknown long-term risk
Individual responses vary. Timeline based on commonly reported research observations.
02Research
Free with emailWhat the research shows
Graded on a research bench
Reference pages that put Dihexa next to the compounds people pair it with: roles, evidence, overlap and conflicts. No dosing. Research use only.
Unlock the research summary
Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.
- A summary of the key research
- Safety and side effects
- A link to the PubMed results
You also get the free peptide cheat sheet by email. Unsubscribe anytime.
Have an account? Sign in
03Safety
Dihexa side effects and interactions
Side effects
Use cautionStop use if
- CRITICAL: active cancer or cancer history; HGF/c-Met is a known oncogenic pathway; do not use without medical supervision
- New or worsening neurological symptoms such as severe headache, mood change, or seizure
Common
- No controlled human safety data exists
- Anecdotal: headache, fatigue, irritability or anxiety, insomnia, vivid dreams
Less common
- Theoretical pro-tumorigenic risk; HGF/c-Met signaling is implicated in cancer progression
Who should not use it
Contraindications
Active cancer or a personal history of cancer (HGF/c-Met is an oncogenic pathway); do not use without oncologist oversight. Pregnancy or breastfeeding. History of seizures. Active neurodegenerative disease (unstudied interaction). Concurrent use of other potent nootropics without careful titration. When in doubt, do not use; there is no human safety data.
Interactions
4 pairings in our record: 4 noted as compatible or synergistic. Compatible and synergistic are notes from the record, not safety findings.
Semax
SynergisticHGF pathway (Dihexa) + BDNF/NGF pathway (Semax) — complementary cognitive enhancement
Noopept
CompatibleDifferent primary mechanisms — can complement each other at conservative doses
NSI-189
CompatibleNeurogenesis + synaptic enhancement — complementary cognitive support
Lion's Mane
SynergisticNGF support from Lion's Mane complements HGF-driven effects of Dihexa
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
Need bloodwork before starting?
Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount.
04Dosing
Free with emailDihexa dosage and protocols
- Dose range
- 5 to 40 mg oral per day (anecdotal range; no established human dose)
- Dosing
- Once daily (oral), typically in the morning
- Common vials
- 50mg, 100mg
Unlock the dosing protocols
Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.
- Dose, route, how often and how long
- A titration schedule
- Beginner, intermediate and advanced protocols
- Reconstitution and handling notes
You also get the free peptide cheat sheet by email. Unsubscribe anytime.
Have an account? Sign in
05Prices
Dihexa prices
3 listings from 1 vendor, opening in the Featured order.
- Pack prices
- $79.99 to $99.99
- Lowest per mg
- $0.333/mg
- Vendors
- 1
- Listings
- 3 (nasal, capsule)
Prices as the vendors list them, last recorded 27 October 2026.
| Vendor | Product | Price | Buy |
|---|---|---|---|
Dihexa Aerosol Spray nasal, spray In stock | $79.99 No mg count | Buy Dihexa Aerosol Spray at Disguised Alpha | |
Dihexa 5 mg capsules (60) capsule, 60 capsules (5 mg) In stock | $0.333/mg $99.99 Lowest per mg | Buy Dihexa 5 mg capsules (60) at Disguised Alpha | |
Energize (Dihexa / Semax / Selank) Aerosol Spray nasal, spray In stock | $99.99 No mg count | Buy Energize (Dihexa / Semax / Selank) Aerosol Spray at Disguised Alpha |
Vendors selling Dihexa(1: trust score, certificates, payment, shipping)
- Disguised Alpha3 listings, from $79.99
Trust Score 50/100, 0 of 36 certificate records read, pays by card, crypto, bank transfer, ships to the US, the EU, the UK
Every supplier above is graded 0 to 100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank. How we score these vendors
Price history(2 days with a recorded price)
06Chemistry
Chemistry and structure
- Molecular formula
- C27H44N4O5
- Molecular mass
- 504.7 g/mol
- CAS number
- 1401708-83-5
- IUPAC name
- N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
- Amino acid sequence
- N-hexanoyl-Tyr-Ile-(6)-aminohexanoic amide: a modified dipeptide derivative of angiotensin IV. It retains the Tyr-Ile core of Nle1-AngIV, capped at the N-terminus with hexanoic acid and at the C-terminus with a 6-aminohexanoic acid amide. Not a standard translatable peptide sequence. CAS 1401708-83-5; molecular formula C27H44N4O5.
- Half-life
- Not characterized in humans. Dihexa was engineered for metabolic stability (resistant to plasma and enzymatic degradation) and blood-brain-barrier penetration; in preclinical work its central procognitive effects appear to outlast its plasma presence.
08Questions
Frequently asked questions
Is Dihexa approved or proven to work in humans?
No. Dihexa has never been through a human clinical trial. All evidence is from rodent studies, and it is sold only for research use. Any human use is experimental and unproven.
How does Dihexa work?
In animal studies it promotes the growth of new synapses in the hippocampus. Its proposed mechanism is potentiation of the HGF/c-Met system with downstream PI3K/Akt signaling, but the main paper establishing the HGF/c-Met binding target was retracted in 2025, so the exact target is unconfirmed.
What is the biggest safety concern with Dihexa?
The HGF/c-Met pathway it targets is also involved in tumor growth and metastasis, which creates a theoretical cancer risk with long-term use. Anyone with active or prior cancer should avoid it, and no one should assume it is safe, because there is no human safety data.
What doses do people use?
There is no established human dose. Anecdotal oral use ranges from about 5 to 40 mg once daily in short cycles. These figures are community-derived, not evidence-based.
Is Dihexa the same as Athira's Alzheimer's drug?
No. Athira Pharma (formerly M3 Biotechnology) grew out of the same Washington State University HGF/c-Met research, but its clinical candidate fosgonimeton (ATH-1017) is a different molecule. Dihexa itself remained preclinical.
How many vendors sell Dihexa, and what does it cost per mg?
1 of the vendors BodyHackGuide tracks list Dihexa (3 listings). Among BodyHackGuide's Dihexa listings recorded as in stock with a milligram count, the lowest price per milligram is $0.333/mg at Disguised Alpha and the median is $0.333/mg. The Dihexa prices on BodyHackGuide are vendors' listed prices as BodyHackGuide last recorded them, not transactions; the most recent recorded change to a Dihexa listing is dated 27 October 2026.
Which vendors have third-party COAs for Dihexa on file at BodyHackGuide?
BodyHackGuide holds 9 third-party certificate records for Dihexa, from Optimum Formula and Disguised Alpha and Half Nattys. No editor has read any of BodyHackGuide's 9 certificate records for Dihexa. The laboratory named on BodyHackGuide's Dihexa certificate records is Freedom Diagnostics Testing, and the newest test date on them is 7 August 2026. Each vendor page on BodyHackGuide shows how many certificate records BodyHackGuide holds for that vendor and links to each record that has its own page.
Related
Articles on Dihexa
Free 2026 Peptide Cheat Sheet (PDF)
38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers.
